NCT01664234

Brief Summary

Infants (0-1 yr.) with anticipated difficult airways will be enrolled in the study. Specifically, we will include infants with cleft palate, Pierre Robin, Treacher Collins, trisomy 21, or similar congenital malformations. Patients with American Society of Anesthesiologists physical status scores ≥3 will be excluded, as will those with congenital heart disease and left-to-right shunting. Patients will be randomly assigned to laryngoscopy with or without simultaneous insufflation of oxygen at 4 L/minute. Oxygen will be provided by a flowmeter connected via rigid tubing to the track-mounted endotracheal tube on the AirTraq. Randomization (1:1) will be based on computer-generated codes with random block sizes and stratified by hospital; allocation will be concealed and provided to clinicians via a secure web site that will be accessed shortly before induction of anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2012

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2014

Completed
Last Updated

August 31, 2023

Status Verified

August 1, 2023

Enrollment Period

3 years

First QC Date

August 10, 2012

Last Update Submit

August 30, 2023

Conditions

Keywords

infants with cleft palatePierre RobinTreacher Collinstrisomy 21

Outcome Measures

Primary Outcomes (1)

  • time to oxygen saturation

    The randomized groups will be compared on time between laryngoscope (airtraq) insertion and reaching an oxygen saturation of 90%using a 2-tailed t-test or Wilcoxon-Mann-Whitney test, as appropriate.

    Day 1

Secondary Outcomes (1)

  • mean oxygenation comparison

    Day 1

Study Arms (2)

laryngoscopy with simultaneous insufflation of oxygen

EXPERIMENTAL

Patients will be randomly assigned to laryngoscopy with or without simultaneous insufflation of oxygen at 4 L/minute. Oxygen will be provided by a flowmeter connected via rigid tubing to the track-mounted endotracheal tube on the AirTraq.

Other: laryngoscopy with oxygen

laryngoscopy without simultaneous oxygen insufflation

PLACEBO COMPARATOR

Patients will be randomly assigned to laryngoscopy with or without simultaneous insufflation of oxygen at 4 L/minute. Oxygen will be provided by a flowmeter connected via rigid tubing to the track-mounted endotracheal tube on the AirTraq.

Other: laryngoscopy without oxygen

Interventions

Patients will be randomly assigned to laryngoscopy with or without simultaneous insufflation of oxygen at 4 L/minute. Oxygen will be provided by a flowmeter connected via rigid tubing to the track-mounted endotracheal tube on the AirTraq.

laryngoscopy with simultaneous insufflation of oxygen

Patients will be randomly assigned to laryngoscopy without simultaneous insufflation of oxygen at 4 L/minute.

laryngoscopy without simultaneous oxygen insufflation

Eligibility Criteria

Age1 Month - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • infants (0-2) difficult airways

You may not qualify if:

  • Patients with American Society of Anesthesiologists physical status scores ≥3 congenital heart disease left-to-right shunting

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medizinischen Universität Wien

Vienna, Borschkegasse, 1090, Austria

Location

MeSH Terms

Conditions

Pierre Robin SyndromeMandibulofacial DysostosisDown Syndrome

Interventions

LaryngoscopyOxygen

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCraniofacial DysostosisDysostosesBone Diseases, DevelopmentalBone DiseasesColobomaEye Diseases, HereditaryEye DiseasesIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleChromosome DisordersGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeOtorhinolaryngologic Surgical ProceduresChalcogensElementsInorganic ChemicalsGases

Study Officials

  • Olga Plattner, M.D.

    Medizinischen Universität Wien Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

August 10, 2012

First Posted

August 14, 2012

Study Start

January 1, 2012

Primary Completion

December 30, 2014

Study Completion

December 30, 2014

Last Updated

August 31, 2023

Record last verified: 2023-08

Locations